Compare GDRX & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDRX | STAA |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | 1995 |
| Metric | GDRX | STAA |
|---|---|---|
| Price | $3.36 | $19.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $3.66 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.0M | 780.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | 0.03 | ★ 0.26 |
| Revenue | ★ $796,853,000.00 | $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $5.38 | $8.41 |
| P/E Ratio | $110.67 | ★ $76.15 |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.77 | $15.59 |
| 52 Week High | $5.61 | $35.87 |
| Indicator | GDRX | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 31.21 |
| Support Level | $3.28 | $19.82 |
| Resistance Level | $3.58 | $20.49 |
| Average True Range (ATR) | 0.10 | 0.97 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 15.00 | 6.26 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.